NewGenIvf Group Ltd (NIVF)
NewGenIvf Group Ltd is a Bangkok-based healthcare company listed on NASDAQ under the ticker NIVF. Through its clinic network, the company provides assisted reproductive services for couples and individuals seeking fertility treatment in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. Its service portfolio includes in vitro fertilization (IVF), ICSI, embryo culture, hormonal and infectious disease testing, chromosome screening, hysteroscopy, sperm analysis, sperm sorting, washing and freezing, and egg freezing. The company also supports IVF-related surrogacy arrangements with ancillary care services such as regular health checks, vitamins, supplements, and medicines for surrogate mothers. In addition, it offers value-added support including nutrition guidance, psychological counselling, acupuncture, and translation services. Founded in 2010, NewGenIvf Group operates as an investment holding company within the healthcare providers and services segment.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-NIVF
|
$0.88
|
21.8% Upside
|
Undervalued
|
$127.08 17,572.1% Upside
|
Not available
|
Bargain
|
Weak
|
0.0%
|
December 3, 2026
|
0.2x
|
0.1x
|
0.4x
|
1.74 M
|
5.005 M
|
81.8%
|
48.2%
|
6.4
|
-112.0%
|
